Skip to content
  1. Home
  2. Latest news
  3. Johnson & Johnson named a 2025 Fortune World’s Most Admired Company
johnson-johnson-named-a-2025-fortune-worlds-most-admired-company-0125.png

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

Johnson & Johnson’s purpose is to blend heart, science and ingenuity to profoundly impact health for humanity. Now the company is being recognized for this work, landing a spot on Fortune’s World’s Most Admired Companies list for 23 consecutive years.

What it takes to be a Most Admired Company

To compile the prestigious list, Fortune—in collaboration with consulting firm Korn Ferry (which has conducted the research for the World’s Most Admired Companies list since 1997)—asked more than 3,300 executives to rate the reputation of companies in their respective industries based on nine attributes. Those include a firm’s effectiveness in conducting business globally, social responsibility, innovativeness, value as a long-term investment and ability to attract and retain talented people, among other criteria.

On all of the above, Johnson & Johnson more than delivers.

A focus on health and care

In 2024, Johnson & Johnson continued its exclusive focus on healthcare. The company’s Innovative Medicine and MedTech businesses remain dedicated to tackling the world’s toughest health challenges, whether through the development of breakthrough treatments for today’s most complex diseases or innovating at the intersection of biology and technology.

Johnson & Johnson is honored to once again be among Fortune’s World’s Most Admired Companies.

More from Johnson & Johnson

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.